Effect of Aficamten on Disease and Symptom Burden in Patients With Obstructive Hypertrophic Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
J Am Coll Cardiol 2024 Sep 25;[EPub Ahead of Print], MS Maron, A Masri, ME Nassif, R Barriales-Villa, TP Abraham, M Arad, N Cardim, L Choudhury, B Claggett, CJ Coats, HD Düngen, P Garcia-Pavia, AA Hagège, JL Januzzi, I Kulac, MMY Lee, GD Lewis, CS Ma, M Michels, A Oreziak, AT Owens, JA Spertus, SD Solomon, J Tfelt-Hansen, M van Sinttruije, J Veselka, HC Watkins, DL Jacoby, SB Heitner, S Kupfer, FI Malik, L Meng, A Wohltman, I OlivottoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.